Abstract
alpha2-Adrenergic receptor agonists are analgesic agents, and the alpha2-adrenergic agonist clonidine has been used in clinical studies for regional analgesia after intrathecal administration. We review here recent developments concerning the structure activity relationships of a new class of potent alpha2-adrenergic agonists and their use as analgesic agents. The effect of structure upon cardiovascular side effects is also monitored, such as the prolongation of the QT portion of the cardiac action potential.
Keywords: Adrenergic Receptor, Agonists as Analgesics, Imidazoles and Imidazolines, Adrenoceptor Agonists, Catecholamines, Oxazolines
Current Topics in Medicinal Chemistry
Title: Alpha2-Adrenergic Receptor Agonists as Analgesics
Volume: 1 Issue: 3
Author(s): Robert E. Boyd
Affiliation:
Keywords: Adrenergic Receptor, Agonists as Analgesics, Imidazoles and Imidazolines, Adrenoceptor Agonists, Catecholamines, Oxazolines
Abstract: alpha2-Adrenergic receptor agonists are analgesic agents, and the alpha2-adrenergic agonist clonidine has been used in clinical studies for regional analgesia after intrathecal administration. We review here recent developments concerning the structure activity relationships of a new class of potent alpha2-adrenergic agonists and their use as analgesic agents. The effect of structure upon cardiovascular side effects is also monitored, such as the prolongation of the QT portion of the cardiac action potential.
Export Options
About this article
Cite this article as:
Boyd E. Robert, Alpha2-Adrenergic Receptor Agonists as Analgesics, Current Topics in Medicinal Chemistry 2001; 1 (3) . https://dx.doi.org/10.2174/1568026013395182
DOI https://dx.doi.org/10.2174/1568026013395182 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Chronic Kidney Disease
The scope of the special thematic issue includes but not limited to the mechanism of chronic kidney disease (CKD), the treatment of renal fibrosis and early diagnosis of CKD and so on. We also welcome manuscripts from other scientific research area with respect to internal medicine. Cell death has been ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effect of Stress Management Program on Perceived Stress in Patients with Type 2 Diabetes: A Randomized Controlled Trial
Current Diabetes Reviews Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
Current Cancer Drug Targets Anti-Oxidative Polyphenolic Compounds of Cocoa
Current Pharmaceutical Biotechnology Genetics of Gestational Diabetes Mellitus
Current Medicinal Chemistry Metabolic Association between Leptin and the Corticotropin Releasing Hormone
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Predictors of Drug-induced Prolongation of the QT Interval
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Anti-Aging Effect of Metformin: A Molecular and Therapeutical Perspective
Current Pharmaceutical Design Antioxidant Therapy in Critically Septic Patients
Current Drug Targets Carotenoids as Modulators of Intracellular Signaling Pathways
Current Signal Transduction Therapy Recent Advances in the Analyses of Phytoestrogens and Their Role in Human Health
Current Pharmaceutical Analysis Bestatin as an Experimental Tool in Mammals
Current Drug Metabolism Statins And Stroke
Current Medicinal Chemistry HDACs and HDAC Inhibitors in Urothelial Carcinoma – Perspectives for an Antineoplastic Treatment
Current Medicinal Chemistry Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors
Current Cancer Therapy Reviews Catecholamines, Sympathetic Innervation and Immunity: Role in Experimental and Rheumatoid Arthritis
Letters in Drug Design & Discovery Regulatory T Cells and Tolerogenic Dendritic Cells as Critical Immune Modulators in Atherogenesis
Current Pharmaceutical Design Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients
Current Vascular Pharmacology The Endocannabinoid System in Ageing: A New Target for Drug Development
Current Drug Targets The Blood-Brain Barrier as a Cause of Obesity
Current Pharmaceutical Design